Items by Taylor, Denise
|Up a level|
Number of items: 28.
Gage, H., Family, H., Murphy, F., Williams, P., Sutton, J. and Taylor, D., 2015. Comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia. Journal of Advanced Nursing, 71 (3), pp. 547-558. Item availability may be restricted.
Taylor, D., 2014. How pharmacists can improve the care of vulnerable patients. Pharmaceutical Journal
Rutter, P., Taylor, D. A. and Branford, D., 2013. Mental health curricula at schools of pharmacy in the United Kingdom and recent graduates' readiness to practice. American Journal of Pharmaceutical Education, 77 (7), 147.
Haddington, N., Hanning, L., Weiss, M. and Taylor, D. A., 2013. The use of a high-fidelity simulation manikin in teaching clinical skills to fourth year undergraduate pharmacy students. Pharmacy Education, 13 (1), pp. 54-60.
Taylor, D., Sutton, J. and Dawson, H., 2012. User and staff perspectives of clozapine clinic services. In: Clinical Pharmacist. Vol. S1. , S6-7.
Taylor, D. A., Yuen, S., Emond, A. and Hunt, L., 2012. An interprofessional pediatric prescribing workshop. American Journal of Pharmaceutical Education, 76 (6), 111.
Taylor, D., Bleakley, S. and Donoghue, J., 2011. Pharmacists should support the upcoming Depression Awareness Week (11-17 April). Clinical Pharmacist, 3 (4), p. 104.
Dawson, H. E., Sutton, J. and Taylor, D. A., 2010. Recruitment of individuals with enduring mental health conditions for health services research. International Journal of Pharmacy Practice, 18 (Suppl 1), pp. 2-3.
Taylor, D. A., 2009. Lay Perspectives of Medicines for Dementia: a Qualitative Study. Thesis (Doctor of Philosophy (PhD)). University of Bath.
Sutton, J. and Taylor, D. A., 2009. Clinical governance issues arising from the Mental Health and Learning Disabilities Pharmacy Workforce Survey (England) 2006. International Journal of Pharmacy Practice, 17 (3), pp. 171-179.
Maidment, I., Taylor, D. A. and Branford, D., 2007. Talking about medicines” — agreeing on the way forward. Hospital Pharmacist, 14, p. 74.
Sutton, J. and Taylor, D. A., 2006. Clinical governance issues arising from the Mental Health and Learning Disabilities Pharmacy Workforce Survey 2006. International Journal of Pharmacy Practice, 2 (Suppl), B24-B25.
Taylor, D., 2006. What does being a designated medical practitioner involve? Prescriber, 17 (19), pp. 36-44.
Taylor, D. A., 2005. Dementia in presentation and management of common mental disorders: an open learning course for pharmacists. In: Continuing pharmacy practice education, 2005-01-01, Manchester University.
Taylor, D. A., Griffiths, H., Hopkins, C., Hughes, G., Miks, J., Bullock, R. and Jones, R., 2003. Audit of NICE guidance for the use of Acetylcholinerases. Journal of Psychopharmacology, 17 (3 (Suppl)), A56-A56.
Swart, J., Taylor, A. and Taylor, D. A., 2003. The impact of reflection on clinical pharmacy practice : initial findings. International Journal of Pharmacy Practice, 11, R99.
McNulty, C., Logan, M., Donald, I. P., Ennis, D., Taylor, D. A., Baldwin, R. N., Bannerjee, M. and Cartwright, K. A., 1997. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. Journal of Antimicrobial Chemotherapy, 40 (5), pp. 707-711.